Class 2 Medicines Recall: Seretide Accuhaler 50 microgram/250 microgram/dose inhalation powder, pre-dispensed
Glaxo Wellcome UK Limited is recalling one lot of Seretide Accuhaler 50/250mcg because a manufacturing issue has resulted in a small number of units not delivering the full number of doses. (EL (18) A/04)
Product information
MDR number
MDR 61-02/18
Company name
Glaxo Wellcome UK Ltd
Product description
Seretide Accuhaler 50 microgram/250 microgram/dose inhalation powder, pre-dispensed
(Salmeterol/Fluticasone Propionate)
PL number
PL 10949/0315
Lot number/expiry
- Lot Number: 5K8W
- Expiry Date: 04-2019
- Pack Size: 1 x 60 doses
- First Distributed: 29 August 2017
Brief description of the problem
Glaxo Wellcome UK Limited is recalling the above Lot of Seretide Accuhaler 50/250mcg because a manufacturing issue with this Lot has been identified which has resulted in a small number of units not delivering the full number of doses.
Please note, this is not a patient level recall.
Advice for healthcare professionals
Please quarantine any remaining stock of this Lot and return to the original supplier for credit. The location of Lot number and expiry is as shown in the images in the document below.
Advice for wholesalers
Quarantine any remaining stock of this Lot and return to the original supplier for credit.
Medical information enquiries
Please contact GSK via customercontactuk@gsk.com, Live Chat facility or by calling 0800 221 441 (option 4).
Stock enquiries
please refer to the GSK website or contact 0800 221 441 (option 1).
Download document
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS regional teams are asked to forward this to relevant clinics, hospitals, mental health trusts, general practitioners and community pharmacists for information.